Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-16-000037

Options or other derivatives

  • Chief Science/Medical Officer acquired 20,479 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STRAYER DAVID R · Chief Science/Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-07-29 Grant or award : show line 1 in the form Incentive Rights +20,479 $0.13 $2,662 20,479 D
Loading xslF345X03/primary_doc.xml…